1. Volume 135, Issue 5, Pages 1517-1525 (November 2008)
Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac 
Loren Laine, Sean P. Curtis, Michael Langman, Dennis M. Jensen, Byron Cryer, Amarjot Kaur, Christopher P. Cannon 
Gastroenterology 
Volume 135, Issue 5, Pages (November 2008)
DOI: /j.gastro
Copyright © 2008 AGA Institute Terms and Conditions

2. Figure 1
Time-to-event analyses in the intent-to-treat population. (A) Cumulative incidence of lower GI clinical events (bleeding, perforation, or obstruction confirmed by adjudication committee). (B) Cumulative incidence of lower GI bleeding events confirmed by the adjudication committee.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2008 AGA Institute Terms and Conditions